MedTrace Logo

Biomarker for Rapid Diagnosis of Hemispheric Stroke

NCT00916864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2011-06-23

No results posted yet for this study

Summary

The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments \[NR2-peptide\] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.

Conditions

  • Acute Stroke

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Helmuth Steinmetz, MD · Department of Neurology, Goethe-University, Frankfurt, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00916864 on ClinicalTrials.gov